Robert Huddart

Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma

Yohann Loriot, Andrea Necchi, Se Hoon Park et al. · New England Journal of Medicine · 2019 · 1.4K citations · Full text

Medicine, Oncology, Pharmacology +15

Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer

Nicholas D. James, Syed A. Hussain, Emma Hall et al. · New England Journal of Medicine · 2012 · 950 citations · Full text

Medicine, Oncology, Urology +9

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

David P. Dearnaley, Matthew R. Sydes, John D. Graham et al. · The Lancet Oncology · 2007 · 908 citations

Medicine, Oncology, Radiation Oncology +17

Multiple newly identified loci associated with prostate cancer susceptibility

Rosalind A. Eeles, Zsofia Kote‐Jarai, Graham G. Giles et al. · Nature Genetics · 2008 · 850 citations

Medicine, Molecular Genetics, Oncology +12

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 648 citations · Full text

Medicine, Oncology, Pharmacology +11